LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance

Overview of attention for article published in Frontiers in oncology, June 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 2,370 followers.

RT @RobotRrid: RRIDs were included in the Frontiers in Oncology paper "LAPTM5-CD40 Crosstalk in Glioblastoma Invasion and…" (https://t.co/Z…

RRIDs were included in the Frontiers in Oncology paper "LAPTM5-CD40 Crosstalk in Glioblastoma Invasion and…" (https://t.co/Zg4LNtzkZf). RRIDs like this improve reproducibility in scientific research. #accelerateopenscience #ReproducibleResearch

RT @HdNeurooncology: Check out the publication on LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance. https://t.co/…

Check out the publication on LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance. https://t.co/ed496QAk5A Five PIs of the #SFB1389 #UNITE #glioblastoma https://t.co/dWN9JNdQZH contributed to this work.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.